Our agreement with @GlobalFund for up to 6 million treatment courses of our #COVID19 oral treatment will help to accelerate access for high-risk patients in need across 132 low-and-middle-income countries: on.pfizer.com/3xIMjfu
@AlbertBourla | 58,131 followers
Replying to @AlbertBourla
Pfizer's oral treatment is not approved, but is authorized for emergency use by the FDA to treat mild-to-moderate COVID-19 in high-risk patients 12+, weighing at least 40 kg, with positive results of SARS-CoV-2 viral testing. See safety info: COVID19oralRx.com.

Engagement Map



No retweeters found
11 retweeters not shown
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.